Wave life sciences to present at chardan 8th annual genetic medicines conference

Cambridge, mass., sept. 30, 2024 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage biotechnology company focused on unlocking the broad potential of rna medicines to transform human health, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to participate in an analyst-led fireside chat at the chardan 8th annual genetic medicines conference in new york city on tuesday, october 1, 2024, at 1:00 p.m. et.
WVE Ratings Summary
WVE Quant Ranking